Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

RecruitingOBSERVATIONAL
Enrollment

4,680

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

August 31, 2025

Conditions
Lennox Gastaut Syndrome
Trial Locations (4)

43205

RECRUITING

Nationwide Children's, Columbus

48109

RECRUITING

C.S. Mott Children's Hospital, Ann Arbor

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63110

RECRUITING

St. Louis Children's Hospital, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Nationwide Children's Hospital

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of Pittsburgh

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

St. Louis Children's Hospital

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

Nemours Children's Health System

OTHER

collaborator

Stanford University

OTHER

collaborator

Monroe Carell Jr. Children's Hospital at Vanderbilt

OTHER

collaborator

University of North Carolina

OTHER

collaborator

Duke University

OTHER

collaborator

Indiana University

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Nicklaus Children's Hospital f/k/a Miami Children's Hospital

OTHER

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT05374824 - Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome | Biotech Hunter | Biotech Hunter